Immune checkpoint inhibitors in luminal gastrointestinal malignancies: going beyond MSI-H/dMMR, TMB  and PD-L1

Immunotherapy, Ahead of Print.

Source: Immunotherapy - June 13, 2022 Category: Allergy & Immunology Authors: Daniel S Lefler Adam E Snook Babar Bashir Source Type: research